Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.

MLA

Kawano, Takeshi, et al. “Depsipeptide Enhances Imatinib Mesylate-Induced Apoptosis of Bcr-Abl-Positive Cells and Ectopic Expression of Cyclin D1, c-Myc or Active MEK Abrogates This Effect.” Anticancer Research, vol. 24, no. 5A, Sept. 2004, pp. 2705–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15517875&authtype=sso&custid=ns315887.

APA

Kawano, T., Horiguchi-Yamada, J., Iwase, S., Akiyama, M., Furukawa, Y., Kan, Y., & Yamada, H. (2004). Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. Anticancer Research, 24(5A), 2705–2712.

Chicago

Kawano, Takeshi, Junko Horiguchi-Yamada, Satsuki Iwase, Masaharu Akiyama, Yusuke Furukawa, Yasuhiko Kan, and Hisashi Yamada. 2004. “Depsipeptide Enhances Imatinib Mesylate-Induced Apoptosis of Bcr-Abl-Positive Cells and Ectopic Expression of Cyclin D1, c-Myc or Active MEK Abrogates This Effect.” Anticancer Research 24 (5A): 2705–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15517875&authtype=sso&custid=ns315887.